The Primary Care Crisis: Why Payment Reform Is Essential for Patient Outcomes The U.S. health care system faces a persistent challenge: balancing the essential role of primary care with the …
weight loss
-
-
Tamil actor Arya has publicly shared his strategy for maintaining physical fitness, noting that he reduces his sugar intake by approximately 80 percent when adhering to a strict diet. According …
-
Wegovy’s Pill Form Approved by FDA, Expanding Access to GLP-1 Weight-Loss Therapy The U.S. Food and Drug Administration (FDA) has approved the oral form of semaglutide, the active ingredient in …
-
A secret shopper study published in the Journal of the American Medical Association found that nearly 50 direct-to-consumer telehealth sites prescribe GLP-1 medications for weight loss. The research, conducted by …
-
The ketogenic (keto) diet is a high-fat, low-carbohydrate eating plan designed to put the body into a metabolic state called ketosis. In this state, the body burns fat for fuel …
-
Hair loss is a reported side effect for some patients using glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and …
-
46-Year-Old Fitness Coach Lost 25 kg in 24 Weeks Through Sustainable Methods, Says Report A 46-year-old fitness coach in India reportedly lost 25 kilograms over 24 weeks using non-crash diet …
-
Ozempic (semaglutide) is an FDA-approved GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes. According to the U.S. Food and Drug Administration (FDA), the medication …
-
Adults taking glucagon-like peptide-1 (GLP-1) receptor agonists for weight management report improvements in professional and social outcomes, according to recent survey data. A study published in the journal PLOS ONE …
-
How a Gastroenterologist-Approved Avocado and Beans Recipe Can Help You Meet Daily Fiber Goals Consuming adequate dietary fiber is critical for digestive health. A recent recipe combining avocado and beans, …